European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 11 May 2026 - 16:30

Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Olazax, olanzapine, Date of authorisation: 11/12/2009, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 11 May 2026 - 16:15

Human medicines European public assessment report (EPAR): Olazax, olanzapine, Date of authorisation: 11/12/2009, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Tobi Podhaler, tobramycin, Date of authorisation: 20/07/2011, Revision: 25, Status: Authorised

Submitted by Anonymous (not verified) on 11 May 2026 - 16:11

Human medicines European public assessment report (EPAR): Tobi Podhaler, tobramycin, Date of authorisation: 20/07/2011, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation: 24/05/2022, Revision: 6, Status: Authorised

Submitted by Anonymous (not verified) on 11 May 2026 - 16:02

Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation: 24/05/2022, Revision: 6, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More